US agency approves 'five-day-after' contraceptive pill

Aug 14, 2010

A US regulatory agency on Friday approved an emergency contraceptive pill that can prevent pregnancy if taken up to five days after unprotected sex.

The Food and Administration said it granted approval for the drug, called ella, after two phase III clinical trials that "provided compelling data on efficacy and sufficient information on safety."

The drug, manufactured by French firm HRA Pharma, successfully "prevents pregnancy when taken orally within 120 hours (five days) after a failure or unprotected intercourse," the FDA said in a statement.

"It is not intended for routine use as a contraceptive," the agency added.

The drug works by inhibiting or delaying ovulation, and has side effects similar to other emergency contraceptives already on the market, such as Plan B, which prevents if taken within 72 hours after intercourse.

The drug's approval followed a positive recommendation by an FDA advisory committee on June 17.

The drug has been available in Europe since May 2009, under the name ellaOne, and will be distributed into the United States by New Jersey-based Watson Pharma Inc.

Explore further: New treatment approved for rare form of hemophilia

add to favorites email to friend print save as pdf

Related Stories

FDA panel to consider new 'morning-after pill'

Jun 08, 2010

A Food and Drug Administration advisory committee will meet June 17 to consider whether the agency should approve a new emergency contraceptive that studies show is more effective than Plan B, the only "morning-after pill" ...

'Morning After Pill' Works up to 5 Days After Sex

Feb 22, 2010

(PhysOrg.com) -- A team of researchers from the United States and Europe has published new evidence supporting the use of ulipristal acetate as an effective alternative to levonorgestrel (marketed as Plan B®) for emergency ...

New morning-after pill works for up to 5 days

Jan 29, 2010

(AP) -- A new type of morning-after pill is more effective than the most widely used drug at preventing pregnancies in women who had unprotected sex and also works longer, for up to five days, a new study says.

FDA OKs morning-after pill retail sale

Aug 24, 2006

Over-the-counter sale of Plan B, or the morning-after contraceptive pill was approved by the U.S. Food and Drug Administration Thursday.

New 5-Day 'Morning-After' Pill Tested For U.S. Approval

Jan 22, 2010

(PhysOrg.com) -- Currently, women who seek emergency contraception within 72 hours of intercourse can receive copper intrauterine devices. Though the devices are very effective at preventing pregnancy, they ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

10 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0